Preclinical and clinical data for factor Xa and “universal” reversal agents(,,)

por Milling, Truman J., Kaatz, Scott
Publicado 2016

Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents

por Milling, Truman J., Kaatz, Scott
Publicado 2016

Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed

por Milling, Truman J., Spyropoulos, Alex C.
Publicado 2016

Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed(,,)

por Milling, Truman J., Spyropoulos, Alex C.
Publicado 2016

A review of guidelines on anticoagulation reversal across different clinical scenarios – Is there a general consensus?

por Milling, Truman J., Pollack, Charles V.
Publicado 2020

Heparin-Induced Thrombocytopenia Associated with Massive Intracardiac Thrombosis: A Case Report

por Ahmed, Atheer, AL-Mondhiry, Hamid, Milling, Truman J., Campbell, David
Publicado 2012

Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs

por Nielsen, Peter Brønnum, Milling, Truman J., Lip, Gregory Y. H.
Publicado 2021

Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals

por Refaai, Majed A., Bajcic, Paolo, McNeill, Robert, Hood, Christopher, Milling, Truman J.
Publicado 2023

Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review

por Milling, Truman J., Fromm, Christian, Ganetsky, Michael, Pallin, Daniel J., Cong, Julie, Singer, Adam J.
Publicado 2017

INR and vitamin K–dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma

por Hood, Christopher, Goldstein, Joshua N., Milling, Truman J., Refaai, Majed A., Bajcic, Paolo, Goldstein, Brahm, Sarode, Ravi
Publicado 2022

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal

por Refaai, Majed A., Goldstein, Joshua N., Lee, Martin L., Durn, Billie L., Milling, Truman J., Sarode, Ravi
Publicado 2015

Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies

por Milling, Truman J., Refaai, Majed A., Goldstein, Joshua N., Schneider, Astrid, Omert, Laurel, Harman, Amy, Lee, Martin L., Sarode, Ravi
Publicado 2015

Safety of a Four‐factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials

por Milling, Truman J., Refaai, Majed A., Sarode, Ravi, Lewis, Brandon, Mangione, Antoinette, Durn, Billie L., Harman, Amy, Lee, Martin L., Goldstein, Joshua N.
Publicado 2016

Rationale and design of a statewide telestroke registry: Lone Star Stroke Consortium Telestroke Registry (LeSteR)

por Astudillo, Cesar, Ankrom, Christy, Trevino, Alyssa, Malazarte, Rene M, Bambhroliya, Arvind B, Savitz, Sean, Topel, Christopher H, Milling, Truman J, Wu, Tzu-Ching
Publicado 2019

Smartphone imaging repository: a novel method for creating a CT image bank

por Dula, Adrienne N., Milling, Truman J., Johnston, S. Claiborne, Aydelotte, Jayson, Peil, Gary W., Robinson, Alec, Asif, Kaiz, Pan, Stephen, Parekh, Sohan, Warach, Steven
Publicado 2023

Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban

por Benz, Alexander P., Xu, Lizhen, Eikelboom, John W., Middeldorp, Saskia, Milling, Truman J., Crowther, Mark, Yue, Patrick, Conley, Pamela, Lu, Genmin, Connolly, Stuart J.
Publicado 2022

Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Ra...

por Refaai, Majed A., Kothari, Truptesh H., Straub, Shana, Falcon, Jacob, Sarode, Ravi, Goldstein, Joshua N., Brainsky, Andres, Omert, Laurel, Lee, Martin L., Milling, Truman J.
Publicado 2017

Use of deep artificial neural networks to identify stroke during triage via subtle changes in circulating cell counts

por O’Connell, Grant C., Walsh, Kyle B., Smothers, Christine G., Ruksakulpiwat, Suebsarn, Armentrout, Bethany L., Winkelman, Chris, Milling, Truman J., Warach, Steven J., Barr, Taura L.
Publicado 2022

Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients

por Milling, Truman J., King, Ben, Yue, Patrick, Middeldorp, Saskia, Beyer-Westendorf, Jan, Eikelboom, John W., Crowther, Mark, Xu, Lizhen, Verhamme, Peter, Siegal, Deborah M., Connolly, Stuart J.
Publicado 2021

Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel

por Fermann, Gregory J., Cash, Brooks D., Coelho‐Prabhu, Nayantara, Maegele, Marc, Bingisser, Roland, Sehgal, Vinay, Cohen, Alexander T., Golden, Anna Hundt, Russo, Jon, Price, Mark, Mangel, Allen, Koch, Bruce, Christoph, Mary J., Milling, Truman J.
Publicado 2023